Please login to the form below

Not currently logged in
Email:
Password:

bacterial resistance

This page shows the latest bacterial resistance news and features for those working in and with pharma, biotech and healthcare.

GSK takes new-class antibiotic into phase 3 for serious infections

GSK takes new-class antibiotic into phase 3 for serious infections

Because it works in a different way to any currently-approved antibiotic, gepotidacin could sidestep bacterial resistance mechanisms. ... EAGLE-1 will compare gepotidacin – a triazaacenaphthylene bacterial topoisomerase inhibitor developed in

Latest news

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    With an estimated 25, 000 deaths in Europe alone and one person dying every 15 minutes in the US because of drug-resistant bacterial infections, antimicrobial resistance (AMR) is undoubtedly one ... latest World Bank report, Pulling Together to Beat

  • The impending threat of antibiotic resistance The impending threat of antibiotic resistance

    The frequency of antibiotic resistance in a bacterial culture is in the order of one antibiotic resistant mutation in 100 million bacteria. ... Combining two existing antibiotics to see if they can overcome antibiotic resistance or.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics